Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α/NF κ B and Enhancing Nrf2/HO-1"

Hai-Han Liao; Jin-Xiu Zhu; Hong Feng; Jian Ni; Nan Zhang; Si Chen; Huang-Jun Liu; Zheng Yang; Wei Deng; Qi-Zhu Tang

doi:10.1155/2021/9812928

Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α/NF κ B and Enhancing Nrf2/HO-1"

Oxid Med Cell Longev. 2021 May 4:2021:9812928. doi: 10.1155/2021/9812928. eCollection 2021.

Authors

Hai-Han Liao^{1

2

3}, Jin-Xiu Zhu^{1

2

3}, Hong Feng⁴, Jian Ni^{1

2

3}, Nan Zhang^{1

2

3}, Si Chen^{2

3}, Huang-Jun Liu^{1

2

3}, Zheng Yang^{1

2

3}, Wei Deng^{1

2

3}, Qi-Zhu Tang^{1

2

3}

Affiliations

¹ Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
² Cardiovascular Research Institute of Wuhan University, Wuhan, China.
³ Hubei Key Laboratory of Cardiology, Wuhan, China.
⁴ Department of Gerontology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Abstract

[This corrects the article DOI: 10.1155/2017/8370593.].

Publication types

Published Erratum